407 related articles for article (PubMed ID: 24530541)
1. Induction of interferon-gamma and downstream pathways during establishment of fetal persistent infection with bovine viral diarrhea virus.
Smirnova NP; Webb BT; McGill JL; Schaut RG; Bielefeldt-Ohmann H; Van Campen H; Sacco RE; Hansen TR
Virus Res; 2014 Apr; 183():95-106. PubMed ID: 24530541
[TBL] [Abstract][Full Text] [Related]
2. Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus.
Smirnova NP; Webb BT; Bielefeldt-Ohmann H; Van Campen H; Antoniazzi AQ; Morarie SE; Hansen TR
Virus Res; 2012 Aug; 167(2):329-36. PubMed ID: 22659490
[TBL] [Abstract][Full Text] [Related]
3. Acute non-cytopathic bovine viral diarrhea virus infection induces pronounced type I interferon response in pregnant cows and fetuses.
Smirnova NP; Bielefeldt-Ohmann H; Van Campen H; Austin KJ; Han H; Montgomery DL; Shoemaker ML; van Olphen AL; Hansen TR
Virus Res; 2008 Mar; 132(1-2):49-58. PubMed ID: 18053605
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune responses to in utero infection with bovine viral diarrhea virus.
Hansen TR; Smirnova NP; Webb BT; Bielefeldt-Ohmann H; Sacco RE; Van Campen H
Anim Health Res Rev; 2015 Jun; 16(1):15-26. PubMed ID: 26050568
[TBL] [Abstract][Full Text] [Related]
5. Bovine maternal, fetal and neonatal responses to bovine viral diarrhea virus infections.
Kelling CL; Topliff CL
Biologicals; 2013 Jan; 41(1):20-5. PubMed ID: 23084809
[TBL] [Abstract][Full Text] [Related]
6. Maternal and fetal response to fetal persistent infection with bovine viral diarrhea virus.
Hansen TR; Smirnova NP; Van Campen H; Shoemaker ML; Ptitsyn AA; Bielefeldt-Ohmann H
Am J Reprod Immunol; 2010 Oct; 64(4):295-306. PubMed ID: 20678166
[TBL] [Abstract][Full Text] [Related]
7. Fetal Lymphoid Organ Immune Responses to Transient and Persistent Infection with Bovine Viral Diarrhea Virus.
Knapek KJ; Georges HM; Van Campen H; Bishop JV; Bielefeldt-Ohmann H; Smirnova NP; Hansen TR
Viruses; 2020 Jul; 12(8):. PubMed ID: 32731575
[TBL] [Abstract][Full Text] [Related]
8. "Self" and "nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells.
Schweizer M; Mätzener P; Pfaffen G; Stalder H; Peterhans E
J Virol; 2006 Jul; 80(14):6926-35. PubMed ID: 16809298
[TBL] [Abstract][Full Text] [Related]
9. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
[TBL] [Abstract][Full Text] [Related]
10. Expression of type I interferon-induced antiviral state and pro-apoptosis markers during experimental infection with low or high virulence bovine viral diarrhea virus in beef calves.
Palomares RA; Walz HG; Brock KV
Virus Res; 2013 May; 173(2):260-9. PubMed ID: 23458997
[TBL] [Abstract][Full Text] [Related]
11. Transplacental infection with non-cytopathic bovine viral diarrhoea virus types 1b and 2: viral spread and molecular neuropathology.
Bielefeldt-Ohmann H; Tolnay AE; Reisenhauer CE; Hansen TR; Smirnova N; Van Campen H
J Comp Pathol; 2008; 138(2-3):72-85. PubMed ID: 18295788
[TBL] [Abstract][Full Text] [Related]
12. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the type I interferon pathway during persistent and transient bovine viral diarrhea virus infection.
Shoemaker ML; Smirnova NP; Bielefeldt-Ohmann H; Austin KJ; van Olphen A; Clapper JA; Hansen TR
J Interferon Cytokine Res; 2009 Jan; 29(1):23-35. PubMed ID: 19014339
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the viral RNA level and upregulation of innate immunity in spleen of cattle persistently infected with bovine viral diarrhea virus.
Yamane D; Kato K; Tohya Y; Akashi H
Vet Microbiol; 2008 May; 129(1-2):69-79. PubMed ID: 18155368
[TBL] [Abstract][Full Text] [Related]
16. Bovine viral diarrhea virus cyclically impairs long bone trabecular modeling in experimental persistently infected fetuses.
Webb BT; Norrdin RW; Smirnova NP; Van Campen H; Weiner CM; Antoniazzi AQ; Bielefeldt-Ohmann H; Hansen TR
Vet Pathol; 2012 Nov; 49(6):930-40. PubMed ID: 22362966
[TBL] [Abstract][Full Text] [Related]
17. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
18. Experimental infection of pregnant goats with bovine viral diarrhea virus (BVDV) 1 or 2.
Passler T; Riddell KP; Edmondson MA; Chamorro MF; Neill JD; Brodersen BW; Walz HL; Galik PK; Zhang Y; Walz PH
Vet Res; 2014 Apr; 45(1):38. PubMed ID: 24708266
[TBL] [Abstract][Full Text] [Related]
19. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
20. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
